1. Home
  2. Analysis
  3. Nuplazid
  4. Drisdol

Nuplazid and Drisdol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nuplazid (pimavanserin tartrate) and Drisdol (ergocalciferol). Common drug interactions include pneumonia among females and oedema peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Nuplazid and Drisdol. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Nuplazid?

Nuplazid has active ingredients of pimavanserin tartrate. eHealthMe is studying from 47,103 Nuplazid users. Check the latest studies of Nuplazid.

What is Drisdol?

Drisdol has active ingredients of ergocalciferol. It is often used in vitamin d. eHealthMe is studying from 1,741 Drisdol users. Check the latest studies of Drisdol.

On Aug, 06, 2026

15 people who take Nuplazid and Drisdol together, and have interactions are studied.

Nuplazid and Drisdol drug interactions.

What are the common drug interactions of Nuplazid and Drisdol, by gender? *:

female:

  1. Pneumonia
  2. Staphylococcal infection (an infection with staphylococcus bacteria)
  3. Hallucination (an experience involving the perception of something not present)
  4. Death
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Insomnia (sleeplessness)
  7. Terminal state (the transitional states between life and biological death)
  8. Swelling
  9. Nonspecific reaction (unspecified reaction)
  10. Adverse drug reaction

male:

  1. Oedema peripheral (superficial swelling)
  2. Balance disorder
  3. Gait disturbance
  4. Oedema (fluid collection in tissue)
  5. Cardiac arrest

What are the common drug interactions of Nuplazid and Drisdol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anxiety
  2. Nonspecific reaction (unspecified reaction)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Gait disturbance
  5. Insomnia (sleeplessness)
  6. Oedema (fluid collection in tissue)
  7. Terminal state (the transitional states between life and biological death)
  8. Swelling
  9. Cardiac arrest
  10. Parkinson's disease

What are the existing conditions these people have? *

  1. Parkinson's Disease: 12 people, 80.00%
  2. Hallucinations (sensations that appear real but are created by your mind): 7 people, 46.67%
  3. Delusion (a false belief or opinion): 3 people, 20.00%
  4. Psychotic Disorder: 2 people, 13.33%
  5. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 13.33%
  6. Nausea And Vomiting: 1 person, 6.67%
  7. Nausea (feeling of having an urge to vomit): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Nuplazid and Drisdol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nuplazid and Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuplazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nuplazid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Drisdol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on pimavanserin tartrate and ergocalciferol (the active ingredients of Nuplazid and Drisdol, respectively), and Nuplazid and Drisdol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.